The protective effects of vaccines have particularly been highlighted during the recent COVID-19 pandemic. Countries able to offer the vaccine demonstrate lowered infection rates and have kick-started the recovery of their economies.
The COVID-19 pandemic has also highlighted the need to proactively develop medical countermeasures to novel pathogens, in addition to advancing supply and manufacturing capacities to meet global demands.
Investing in vaccine manufacturing has both economic and societal benefits, in addition to protecting human health and limiting infection spread.
Comments are closed.